1. Home
  2. VTIX vs MDWD Comparison

VTIX vs MDWD Comparison

Compare VTIX & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VTIX

Virtuix Holdings Inc. Class A Common Stock

N/A

Current Price

$5.92

Market Cap

222.0M

Sector

Technology

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.97

Market Cap

193.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTIX
MDWD
Founded
2013
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer peripheral equipment
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
222.0M
193.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
VTIX
MDWD
Price
$5.92
$16.97
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$36.00
AVG Volume (30 Days)
195.7K
89.7K
Earning Date
08-11-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$48.88
Revenue Next Year
N/A
$35.08
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.39
$14.90
52 Week High
$9.00
$22.51

Technical Indicators

Market Signals
Indicator
VTIX
MDWD
Relative Strength Index (RSI) 40.49 50.53
Support Level $5.78 $16.77
Resistance Level $9.00 $18.71
Average True Range (ATR) 0.95 0.85
MACD -0.24 0.06
Stochastic Oscillator 7.76 67.74

Price Performance

Historical Comparison
VTIX
MDWD

About VTIX Virtuix Holdings Inc. Class A Common Stock

Virtuix Holdings Inc develops technologies for immersive virtual environments, including both simulated and real-world applications. It develops virtual reality hardware and software, including the Omni Pro, an omni-directional treadmill designed to allow users to walk and run in multiple directions inside video games and other virtual worlds. The company operates at the intersection of gaming, fitness, and enterprise virtual reality. It has commercialized three products. The company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. It derives revenue through a combination of hardware sales and recurring software and service income.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: